Tax-driven SOPHiA GENETICS (NASDAQ: SOPH) share sale under 10b5-1 plan

Rhea-AI Filing Summary

SOPHiA GENETICS SA Executive Chairman Jurgi Camblong reported an open-market sale of 17,685 Ordinary Shares at an average price of $5.2772 per share. According to the filing, the shares were sold to satisfy tax withholding obligations tied to restricted stock units that vested on July 3, 2026, under a pre-established Rule 10b5-1(c) trading plan. After this transaction, Camblong directly holds 3,541,122 Ordinary Shares, indicating the sale is small relative to his remaining stake and was executed on a non-discretionary basis.

Insider Trade Summary 10b5-1

Net Seller: 17,685 shares ($93,327)

Net Sell 1 txn

Insider Camblong Jurgi

Role Executive Chairman

Sold 17,685 shs ($93K)

Type	Security	Shares	Price	Value
Sale	Ordinary Shares	17,685	$5.2772	$93K

Holdings After Transaction: Ordinary Shares — 3,541,122 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 17,685 shares Sale price: $5.2772 per share Shares held after transaction: 3,541,122 shares +3 more

6 metrics

Shares sold 17,685 shares Open-market sale on July 7, 2026

Sale price $5.2772 per share Average price for Ordinary Shares sold

Shares held after transaction 3,541,122 shares Direct ownership after July 7, 2026 sale

Transaction type Open-market sale Non-derivative Ordinary Shares

Plan type Rule 10b5-1(c) trading plan Pre-established, non-discretionary sale arrangement

Tax-related nature Sale for tax withholding Obligations from RSU vesting on July 3, 2026

Key Terms

Rule 10b5-1(c) trading plan, restricted stock units, tax withholding obligations, open-market sale

4 terms

Rule 10b5-1(c) trading plan financial

"These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person"

A Rule 10b5-1(c) trading plan is a legally defined, pre-set schedule that lets company insiders automatically buy or sell stock at specified times or under set formulas when they are not in possession of undisclosed, sensitive information. Think of it like an automatic payment plan for trades: because the instructions are written in advance, trades under the plan help protect insiders from allegations of trading on secret information and give investors clearer expectations about when insiders will transact, which can affect liquidity and perceived transparency.

restricted stock units financial

"tax withholding obligations arising in connection with the vesting of restricted stock units on July 3, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"shares sold by the Reporting Person in the open market to satisfy tax withholding obligations"

open-market sale financial

"Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations"

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/08/2026 - 04:02 PM Accepted by SEC EDGAR 07/08/2026 - 04:01 PM Learn about SEC filing dates

FAQ

What insider transaction did SOPHiA GENETICS (SOPH) disclose?

SOPHiA GENETICS disclosed that Executive Chairman Jurgi Camblong sold 17,685 Ordinary Shares at $5.2772 per share. The filing notes the sale was linked to tax withholding on vested restricted stock units and executed under a pre-established Rule 10b5-1(c) trading plan.

Why did Jurgi Camblong sell SOPHiA GENETICS (SOPH) shares?

The shares were sold to cover tax withholding obligations from the vesting of restricted stock units on July 3, 2026. The filing explains these sales were made automatically pursuant to a pre-established Rule 10b5-1(c) trading plan, rather than as discretionary market-timing trades.

How many SOPHiA GENETICS (SOPH) shares did Camblong sell and at what price?

Camblong sold 17,685 Ordinary Shares at an average price of $5.2772 per share. This transaction is described as an open-market sale, specifically flagged as being related to satisfying tax withholding obligations arising from restricted stock unit vesting.

How many SOPHiA GENETICS (SOPH) shares does Camblong hold after the sale?

Following the reported transaction, Camblong directly holds 3,541,122 Ordinary Shares. This context from the filing shows the sale represents only a small portion of his overall stake, with the majority of his ownership position remaining intact after the tax-related sale.

Was the SOPHiA GENETICS (SOPH) insider sale discretionary or under a plan?

The sale was executed under a pre-established Rule 10b5-1(c) trading plan adopted by Camblong. The filing states these trades were made to satisfy tax withholding on vested restricted stock units and explicitly notes they do not represent discretionary trading decisions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Camblong Jurgi

(Last) (First) (Middle)

C/O SOPHIA GENETICS SA

LA PIECE 12

(Street)

ROLLE 1180

(City) (State) (Zip)

SWITZERLAND

(Country)

2. Issuer Name and Ticker or Trading Symbol
SOPHiA GENETICS SA [ SOPH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/07/2026		S		17,685(1)	D	$5.2772	3,541,122	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.

Remarks:

	/s/ Elimara Brunetto as Attorney-in- Fact for Jurgi Camblong	07/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)